Summary
Johnson & Johnson (JNJ) filed an 8-K on January 19, 2015, reporting its financial results for the fourth quarter and full year ended December 28, 2014. The filing includes a press release and supplementary financial data, providing investors with key performance metrics. The report primarily serves to officially announce and detail the company's recent sales and earnings, offering a snapshot of JNJ's financial standing as of year-end 2014. Investors should review the attached press release and supplementary data for a comprehensive understanding of JNJ's financial performance during the specified periods. This includes insights into revenue generation, profitability, and potentially segment-specific results, which are crucial for evaluating the company's operational health and future prospects.
Key Highlights
- 1Johnson & Johnson announced its fourth quarter and full year 2014 sales and earnings results.
- 2The filing was made on January 19, 2015, with the event date being January 19, 2015.
- 3Key financial information is disseminated through an attached press release dated January 20, 2015.
- 4The report includes unaudited comparative supplementary sales data for the periods.
- 5Condensed consolidated statements of earnings for the fourth quarter and full year 2014 are provided.
- 6This 8-K filing serves as the official channel for releasing these financial outcomes to the public and investors.